[HTML][HTML] Thirty years of the International Banff Classification for Allograft Pathology: the past, present, and future of kidney transplant diagnostics
Abstract 2021 marks the 30th anniversary of the original development of the Banff
Classification of Kidney Allograft Pathology, when in August 1991 a group of pathologists …
Classification of Kidney Allograft Pathology, when in August 1991 a group of pathologists …
[HTML][HTML] The revised (2013) Banff classification for antibody-mediated rejection of renal allografts: update, difficulties, and future considerations
M Haas - American Journal of Transplantation, 2016 - Elsevier
The Banff 2013 classification (Banff 2013) for antibody-mediated rejection (ABMR) in renal
allografts represents the first major revision of the original Banff classification for ABMR that …
allografts represents the first major revision of the original Banff classification for ABMR that …
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell–and antibody‐mediated rejection
The XV. Banff conference for allograft pathology was held in conjunction with the annual
meeting of the American Society for Histocompatibility and Immunogenetics in Pittsburgh …
meeting of the American Society for Histocompatibility and Immunogenetics in Pittsburgh …
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for …
M Haas, A Loupy, C Lefaucheur, C Roufosse, D Glotz… - 2018 - Wiley Online Library
The kidney sessions of the 2017 Banff Conference focused on 2 areas: clinical implications
of inflammation in areas of interstitial fibrosis and tubular atrophy (i‐IFTA) and its relationship …
of inflammation in areas of interstitial fibrosis and tubular atrophy (i‐IFTA) and its relationship …
[HTML][HTML] Assessment of tocilizumab (anti–interleukin-6 receptor monoclonal) as a potential treatment for chronic antibody-mediated rejection and transplant …
J Choi, O Aubert, A Vo, A Loupy, M Haas… - American Journal of …, 2017 - Elsevier
Extending the functional integrity of renal allografts is the primary goal of transplant
medicine. The development of donor-specific antibodies (DSAs) posttransplantation leads to …
medicine. The development of donor-specific antibodies (DSAs) posttransplantation leads to …
[HTML][HTML] The Banff 2022 Kidney Meeting Report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics
M Naesens, C Roufosse, M Haas, C Lefaucheur… - American Journal of …, 2024 - Elsevier
Abstract The XVI-th Banff Meeting for Allograft Pathology was held at Banff, Alberta, Canada,
from 19th to 23rd September 2022, as a joint meeting with the Canadian Society of …
from 19th to 23rd September 2022, as a joint meeting with the Canadian Society of …
Depression and the risk of myocardial infarction and coronary death: a meta-analysis of prospective cohort studies
Depression and the Risk of Myocardial Infarction and Coronar... : Medicine Depression and the
Risk of Myocardial Infarction and Coronary Death: A Meta-Analysis of Prospective Cohort …
Risk of Myocardial Infarction and Coronary Death: A Meta-Analysis of Prospective Cohort …
[HTML][HTML] Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: clinical presentation and implications for outcome
In this cohort study (n= 935 transplantations), we investigated the phenotype and risk of graft
failure in patients with histological criteria for antibody-mediated rejection (ABMR) in the …
failure in patients with histological criteria for antibody-mediated rejection (ABMR) in the …
[HTML][HTML] Revisiting the changes in the Banff classification for antibody-mediated rejection after kidney transplantation
The Banff classification for antibody-mediated rejection (ABMR) has undergone important
changes, mainly by inclusion of C4d-negative ABMR in Banff'13 and elimination of …
changes, mainly by inclusion of C4d-negative ABMR in Banff'13 and elimination of …
Tocilizumab and active antibody-mediated rejection in kidney transplantation: a literature review
L Cabezas, T Jouve, P Malvezzi, B Janbon… - Frontiers in …, 2022 - frontiersin.org
Introduction Chronic kidney disease (CKD) is a major public-health problem that increases
the risk of end-stage kidney disease (ESKD), cardiovascular diseases, and other …
the risk of end-stage kidney disease (ESKD), cardiovascular diseases, and other …